Three specific factors explained why these patients have a higher risk of CHD events….

A new drug target for obesity and diabetes may be on the horizon….

Can insulin pumps reduce glycemic variability in type 1 diabetes?… A new cross-sectional observational cohort study looked at continuous subcutaneous insulin infusion (CSII), aka insulin pump, versus multiple daily injections (MDI) to determine which insulin delivery system resulted in less blood glucose variability in type 1 pediatric diabetes patients. Large …

Systematic review relates information regarding the link between memory and statin use….

Weekly vitamin D supplements may help curb pain and depression….

Can age at first pregnancy increase your risk of developing diabetes?…

In our last newsletter of the year on SGLT2 inhibitors we are going to look forward to what is in store for 2014 and beyond. This month, our PharmD candidate, Heather Good, has prepared a special feature on the how this class will expand and how these medications will be …

What’s New on the Horizon? Heather Good, Doctor of Pharmacy, Candidate University of Florida Sodium-glucose co-transporter 2 (SGLT2) inhibitors, the first drugs to actually eliminate glucose from the body, are paving the way for a new wave of diabetes treatment options. Canagliflozin (Invokana®) took the U.S. market by storm when …

Kareo iOS/Free Basic Version  The free Kareo app gives medical professionals an easy and convenient way to keep track of patient appointments. Whether walking the halls of the hospital, commuting to the office, or trying to grab lunch on a busy day, the Kareo app will keep you informed and …

On Thursday night I was presenting a program on insulin to medical professionals and I asked the participants how a patient could go to bed with a normal glucose but wake up with a higher glucose in the morning. I heard words like "somogyi," "rebound" and "dawn phenomenon." Most of …